Marlene Debel - Dec 13, 2024 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP & Chief Risk Officer
Signature
/s/ Taylor Jansen, Authorized Signer
Stock symbol
MET
Transactions as of
Dec 13, 2024
Transactions value $
-$995,149
Form type
4
Date filed
12/17/2024, 04:20 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Options Exercise $450K +13.1K +12.08% $34.33 122K Dec 13, 2024 Direct
transaction MET Common Stock Options Exercise $445K +9.7K +7.98% $45.91 131K Dec 13, 2024 Direct
transaction MET Common Stock Sale -$1.89M -22.8K -17.37% $82.88 109K Dec 13, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Options Exercise $0 -13.1K -100% $0.00 0 Dec 13, 2024 Common Stock 13.1K $34.33 Direct F2
transaction MET Employee Stock Options (right to buy) Options Exercise $0 -9.7K -100% $0.00 0 Dec 13, 2024 Common Stock 9.7K $45.91 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.83 to $82.931, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 The options became exercisable in three substantially equal installments on February 23, 2017, 2018, and 2019.
F3 The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018.